Comprehensive functional characterization revealed TTC26’s critical role in modulating HCC malignancy through oncogenic mechanisms: TTC26 overexpression enhanced proliferative capacity as evidenced by CCK-8 assays, while knockdown models showed proliferation reduction (Figure 8C). This evidence concerns the gene IFT56 and hepatocellular carcinoma.